Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
Faryngeale elektrische stimulatie bij dysfagie na een herseninfarct: PHAST-TRAC
jan 2019 | Neuro-vasculair